IP Verse

Ose Immunotherapeutics competitive analysis

Latest patents of Ose Immunotherapeutics opposed by its competitors

Explore Ose Immunotherapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 17, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP3783027
Dec 3, 2025Method And Compositions For Inducing Differentiation Of Myeloid Derived Suppressor Cell To Treat Cancer And Infectious Diseases1
EP4186927
Apr 23, 2025Methods And Compositions For Modifying Macrophage Polarization Into Pro-Inflammatory Cells To Treat Cancer2
EP3209691
Jul 15, 2020Method And Compositions For Inducing Differentiation Of Myeloid Derived Suppressor Cell To Treat Cancer And Infectious Diseases1
EP2583979
Dec 16, 2015Antibodies Directed Against P19 Subunit Of Human Il-23 - Use For The Preparation Of Therapeutic Molecules1

Latest PTAB cases involving Ose Immunotherapeutics

Discover the latest PTAB cases involving Ose Immunotherapeutics, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Ose Immunotherapeutics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 17, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
OSE IMMUNOTHERAPEUTICS - 5 - -
BYONDIS2 - - -
JANSSEN BIOTECH152616
STRAWMAN471 - - -